Nurix Therapeutics, Inc. - NRIX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 27, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Baker Bros. Advisors LP | 7.2% | 7,527,996 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Baker Bros. Advisors (GP) LLC | 7.2% | 7,527,996 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Julian C. Baker | 7.2% | 7,527,996 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Felix J. Baker | 7.2% | 7,527,996 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Commodore Capital LP | 4.9% | 3,780,055 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Commodore Capital Master LP | 4.9% | 3,780,055 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | FMR LLC | 4.1% | 4,159,940 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Abigail P. Johnson | 4.1% | 4,159,940 | View |
| Nov 05, 2025 | SCHEDULE 13G/A | FMR LLC | 11.5% | 8,787,537 | View |
| Nov 05, 2025 | SCHEDULE 13G/A | Abigail P. Johnson | 11.5% | 8,787,537 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.